Steris PLC (NYSE:STE) Director Mohsen Sohi sold 3,121 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $165.65, for a total transaction of $516,993.65. Following the sale, the director now owns 25,482 shares in the company, valued at $4,221,093.30. The sale was disclosed in a filing with the SEC, which is available at this link.

Steris stock opened at $168.51 on Friday. The firm’s 50 day simple moving average is $153.20 and its 200 day simple moving average is $149.19. The company has a current ratio of 2.41, a quick ratio of 1.86 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $14.29 billion, a PE ratio of 36.63 and a beta of 0.90. Steris PLC has a 1-year low of $118.18 and a 1-year high of $168.61.

Steris (NYSE:STE) last posted its earnings results on Monday, February 10th. The medical equipment provider reported $1.45 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.42 by $0.03. The business had revenue of $774.30 million for the quarter, compared to analyst estimates of $748.45 million. Steris had a net margin of 13.21% and a return on equity of 17.32%. Steris’s revenue was up 11.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.26 EPS. Research analysts forecast that Steris PLC will post 5.58 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, February 25th will be issued a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a yield of 0.88%. The ex-dividend date of this dividend is Monday, February 24th. Steris’s dividend payout ratio (DPR) is presently 30.27%.

A number of research firms recently weighed in on STE. Northcoast Research reaffirmed a “buy” rating on shares of Steris in a report on Wednesday. Stephens upped their target price on shares of Steris from $165.00 to $177.00 and gave the stock an “overweight” rating in a report on Wednesday. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $152.75.

A number of institutional investors have recently bought and sold shares of STE. Squar Milner Financial Services LLC increased its holdings in shares of Steris by 225.9% in the 3rd quarter. Squar Milner Financial Services LLC now owns 176 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 122 shares during the last quarter. Quest Capital Management Inc. ADV bought a new position in shares of Steris in the 3rd quarter worth $26,000. CWM LLC increased its holdings in shares of Steris by 130.9% in the 3rd quarter. CWM LLC now owns 187 shares of the medical equipment provider’s stock worth $27,000 after buying an additional 106 shares during the last quarter. Knuff & Co LLC bought a new position in shares of Steris in the 3rd quarter worth $29,000. Finally, Raab & Moskowitz Asset Management LLC bought a new position in shares of Steris in the 4th quarter worth $32,000. 86.78% of the stock is currently owned by institutional investors and hedge funds.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Article: Are analyst ratings accurate?

Insider Buying and Selling by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.